JP6556873B2 - 経皮吸収製剤 - Google Patents
経皮吸収製剤 Download PDFInfo
- Publication number
- JP6556873B2 JP6556873B2 JP2017564310A JP2017564310A JP6556873B2 JP 6556873 B2 JP6556873 B2 JP 6556873B2 JP 2017564310 A JP2017564310 A JP 2017564310A JP 2017564310 A JP2017564310 A JP 2017564310A JP 6556873 B2 JP6556873 B2 JP 6556873B2
- Authority
- JP
- Japan
- Prior art keywords
- drug reservoir
- drug
- mass
- layer
- sensitive adhesive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016014170 | 2016-01-28 | ||
JP2016014170 | 2016-01-28 | ||
PCT/JP2017/002553 WO2017131034A1 (fr) | 2016-01-28 | 2017-01-25 | Préparation pharmaceutique pour absorption transdermique |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2017131034A1 JPWO2017131034A1 (ja) | 2018-09-06 |
JP6556873B2 true JP6556873B2 (ja) | 2019-08-07 |
Family
ID=59398365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017564310A Active JP6556873B2 (ja) | 2016-01-28 | 2017-01-25 | 経皮吸収製剤 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP6556873B2 (fr) |
TW (1) | TWI710381B (fr) |
WO (1) | WO2017131034A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3558276A1 (fr) | 2016-12-20 | 2019-10-30 | LTS Lohmann Therapie-Systeme AG | Système thérapeutique transdermique contenant de l'asénapine et un polysiloxane ou un polyisobutylène |
MX2019007391A (es) | 2016-12-20 | 2019-08-16 | Lts Lohmann Therapie Systeme Ag | Sistema terapeutico transdermico que contiene asenapina. |
WO2019002204A1 (fr) | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | Système thérapeutique transdermique contenant de l'asénapine et un polymère hybride acrylique de type silicone |
WO2019243452A1 (fr) | 2018-06-20 | 2019-12-26 | Lts Lohmann Therapie-Systeme Ag | Système thérapeutique transdermique contenant de l'asénapine |
CN112789039B (zh) | 2018-10-01 | 2023-10-24 | 久光制药株式会社 | 含有阿塞那平的贴剂 |
CN113226308A (zh) | 2018-10-01 | 2021-08-06 | 久光制药株式会社 | 含有阿塞那平的贴剂 |
CN112823793A (zh) * | 2019-11-20 | 2021-05-21 | 成都康弘药业集团股份有限公司 | 一种含有多奈哌齐的透皮贴剂及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07157423A (ja) * | 1993-12-06 | 1995-06-20 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
JPH09124462A (ja) * | 1995-11-01 | 1997-05-13 | Nitto Denko Corp | 貼付剤および貼付製剤 |
IT1294748B1 (it) * | 1997-09-17 | 1999-04-12 | Permatec Tech Ag | Formulazione per un dispositivo transdermico |
EP1992363B1 (fr) * | 2006-02-28 | 2012-12-19 | Hisamitsu Pharmaceutical Co., Inc. | Preparation pour absorption transdermique |
US8702664B2 (en) * | 2009-02-18 | 2014-04-22 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal preparation |
KR101239150B1 (ko) * | 2012-02-28 | 2013-03-06 | 에스케이케미칼주식회사 | 도네페질-함유 경피흡수제제 및 그의 제조방법 |
-
2017
- 2017-01-25 WO PCT/JP2017/002553 patent/WO2017131034A1/fr active Application Filing
- 2017-01-25 JP JP2017564310A patent/JP6556873B2/ja active Active
- 2017-01-26 TW TW106103164A patent/TWI710381B/zh active
Also Published As
Publication number | Publication date |
---|---|
JPWO2017131034A1 (ja) | 2018-09-06 |
WO2017131034A1 (fr) | 2017-08-03 |
TWI710381B (zh) | 2020-11-21 |
TW201726119A (zh) | 2017-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6556873B2 (ja) | 経皮吸収製剤 | |
US6316022B1 (en) | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures | |
US8337884B2 (en) | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures | |
US5306503A (en) | Patch with a high content of softening ingredients | |
JP4873871B2 (ja) | 粘着剤及び貼付剤 | |
CN107847487B (zh) | 含有阿塞那平的贴剂 | |
US20070264319A1 (en) | Transdermal Antiemesis Delivery System, Method and Composition Therefor | |
JP5542791B2 (ja) | 経皮吸収製剤 | |
JP5615697B2 (ja) | β遮断剤の安定化組成物およびそれを用いた経皮吸収製剤 | |
KR101853082B1 (ko) | 활성제층 및 활성제 변환층을 포함하는 경피 조성물 | |
JPH08505632A (ja) | 活性物質としてガランタミンを有する経皮医療システム | |
JP4824963B2 (ja) | 貼付材及び貼付製剤 | |
KR20120137373A (ko) | 프로필아미노인단 경피 조성물 | |
WO2008050673A1 (fr) | Timbre transdermique adhésif | |
JP2008247899A (ja) | ビソプロロール経皮投与デバイス | |
JP2022190070A (ja) | 貼付剤 | |
KR20200015929A (ko) | 경피 흡수형 제제 | |
JP6457486B2 (ja) | 貼付製剤 | |
JP2002537244A (ja) | デオキシペガニン経皮治療系 | |
JP2003534365A (ja) | 非吸蔵性裏打ち層を有する吸蔵性経皮治療系 | |
US20050186262A1 (en) | Transdermal delivery device for dihydropyridine type calcium antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180521 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190402 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190531 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190702 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190710 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6556873 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |